Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Belatacept may be a promising treatment for alopecia areata.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Older skin has higher cancer risk due to inflammation and stem cell issues.

HuR is essential for Treg function and preventing autoimmunity.

Non-immune factors play a significant role in alopecia areata.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

Stem cells help heal wounds by rapidly dividing and migrating to the wound edge.

scINSIGHT accurately identifies cell clusters and gene patterns in complex data.

Melatonin affects certain genes and pathways involved in cashmere goat hair growth.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

iPSC lines from different tissues share a common miRNA profile, supporting their pluripotent nature.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.